Micah Anderson
Chief Executive Officer en LEEF BRANDS INC. .
Fortuna: 2 M $ al 31/03/2024
Cargos activos de Micah Anderson
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| LEEF BRANDS INC. | Director/Board Member | 06/09/2022 | - |
| Chief Executive Officer | 06/09/2022 | - | |
Leef Holdings, Inc.
 Leef Holdings, Inc. Agricultural Commodities/MillingProcess Industries Leef Holdings, Inc. provides investment services. The company was founded in 2019 and is headquartered in La Jolla, CA. | Chief Executive Officer | - | - |
| Chairman | - | - | |
| Founder | - | - | |
Aya Biosciences, Inc.
 Aya Biosciences, Inc. BiotechnologyHealth Technology Aya Biosciences, Inc. is a neuroscience company that is dedicated to improving the mental health and well-being of patients with neuropsychiatric diseases. The company is based in La Jolla, CA. The company is creating a pipeline of novel, orally active serotonin receptor agonists as a new class of therapeutics. The CEO of the company is Micah Anderson. | Director/Board Member | - | - |
| Chief Executive Officer | - | - |
Historial de carrera de Micah Anderson
Estadísticas
Internacional
| Estados Unidos | 3 |
| Canadá | 2 |
Operativa
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| Chairman | 1 |
Sectorial
| Process Industries | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| LEEF BRANDS INC. | Process Industries |
| Empresas privadas | 2 |
|---|---|
Leef Holdings, Inc.
Leef Holdings, Inc. Agricultural Commodities/MillingProcess Industries Leef Holdings, Inc. provides investment services. The company was founded in 2019 and is headquartered in La Jolla, CA. | Process Industries |
Aya Biosciences, Inc.
Aya Biosciences, Inc. BiotechnologyHealth Technology Aya Biosciences, Inc. is a neuroscience company that is dedicated to improving the mental health and well-being of patients with neuropsychiatric diseases. The company is based in La Jolla, CA. The company is creating a pipeline of novel, orally active serotonin receptor agonists as a new class of therapeutics. The CEO of the company is Micah Anderson. | Health Technology |
- Bolsa de valores
- Insiders
- Micah Anderson
- Experiencia
